2023-2029 Global Medical Silk Fibroin Industry Research & Trends Analysis Report

Medical silk fibroin has good biocompatibility, good cell adhesion, can induce cell differentiation and tissue regeneration, and is biodegradable, which can reduce inflammation and the risk of secondary surgery.
This report aims to provide a comprehensive study of the global market for Medical Silk Fibroin. Report Highlights:
(1) Global Medical Silk Fibroin market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Medical Silk Fibroin market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China Medical Silk Fibroin market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global Medical Silk Fibroin segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Medical Silk Fibroin segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Medical Silk Fibroin, capacity, production and trends.
(7) Medical Silk Fibroin industry supply chain, upstream, midstream and downstream analysis.
According to YH Research, the global market for Medical Silk Fibroin should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Medical Silk Fibroin market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Medical Silk Fibroin market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Nose Bridge Prosthesis segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Medical has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Medical Silk Fibroin include Seidecosa, Caresilk, Seiren Co., DSM, Dadilan, LANXESS, Xi’an ChinWon Biotech, Xinyuan and Huzhou Xintiansi Bio-tech, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Nose Bridge Prosthesis
Artificial Cartilage/Ligament
Silk Fibroin Bone Nail
Artificial Meninges
Cardiovascular Stent
Other
Market segment by application, can be divided into
Medical
Plastic Surgery/Medical Beauty
Other
Market segment by players, this report covers
Seidecosa
Caresilk
Seiren Co.
DSM
Dadilan
LANXESS
Xi’an ChinWon Biotech
Xinyuan
Huzhou Xintiansi Bio-tech
Huzhou Aotesi Bio-chemical